Pages 629 and 630: Structures for cochliomycin C (3) and paecilomycin F (7) should be corrected as shown:Other changes corresponding to this correction are as follows:Page 631: In the third paragraph of the left column, "the configuration of cochliomycin C (3) should be assigned as 4′S,5′R,6′R,10′S" should be changed to "the configuration of cochliomycin C (3) should be assigned as 4′S,5′R,6′S,10′S".The error was caused by the configuration of paecilomycin F (7), which was first assigned as 4′S,5′R,6′R,10′S 1 and later was corrected as 4′S,5′R,6′S,10′S by Liangxiong Xu et al. 2 We apologize for any inconvenience caused by this error.
A novel Gram-negative, aerobic, catalase-and oxidase-positive, non-sporulating, non-motile, rodshaped bacterium, designated strain UST081027-248 T , was isolated from seawater of the Red Sea. Phylogenetic analysis based on 16S rRNA gene sequences showed that strain UST081027-248 T fell within the genus Erythrobacter. Levels of 16S rRNA gene sequence similarity between the novel strain and the type strains of Erythrobacter species ranged from 95.3 % (with Erythrobacter gangjinensis) to 98.2 % (with Erythrobacter citreus). However, levels of DNA-DNA relatedness between strain UST081027-248 T and the type strains of closely related species were below 70 %. Optimal growth of the isolate occurred in the presence of 2.0 % NaCl, at pH 8.0-9.0 and at 28-36 6C. The isolate did not produce bacteriochlorophyll a. The predominant cellular fatty acids were C 17 : 1 v6c, summed feature 8 (C 18 : 1 v6c and/or C 18 : 1 v7c) and C 15 : 0 2-OH. The genomic DNA G+C content of strain UST081027-248 T was 60.4 mol%. Phenotypic properties and phylogenetic distinctiveness clearly indicated that strain
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.